The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies (Q37629155)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies |
scientific article |
Statements
1 reference
The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies (English)
1 reference
Patrick Y Muller
1 reference
Mark Milton
1 reference
Peter Lloyd
1 reference
Jennifer Sims
1 reference
Frank R Brennan
1 reference
5 November 2009
1 reference
1 reference
Identifiers
1 reference